Skip to main content

Soleno Therapeutics Inc

SLNODelisted May 18, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001484565

Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.

Superinvestors holding SLNO, Q1 2026

See all superinvestors

No superinvestor reported holding SLNO in Q1 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of SLNO each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2025

    0 superinvestors holding at quarter end

    Sold out
    Soros Fund Management
  2. Q1 2025

    1 superinvestor holding at quarter end

    New
    Soros Fund Management
  3. Q3 2024

    0 superinvestors holding at quarter end

    Sold out
    Soros Fund Management
  4. Q2 2024

    1 superinvestor holding at quarter end

    Added
    Soros Fund Management (+10.0%)
  5. Q1 2024

    1 superinvestor holding at quarter end

    New
    Soros Fund Management